STEPHANIE EDMUNDS: Open Payments
NPI 1124706957 · AUBURN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$598 in 29 payments from 10 companies in 2025. Trend: 2023 $169 · 2024 $591 · 2025 $598
Food & beverage: $598
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $211 |
| Lilly USA, LLC | 6 | $109 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $109 |
| AstraZeneca Pharmaceuticals LP | 3 | $44 |
| IBSA Pharma Inc. | 2 | $30 |
| Exact Sciences Corporation | 1 | $24 |
| ABBVIE INC. | 1 | $20 |
| Janssen Pharmaceuticals, Inc | 1 | $18 |
| GlaxoSmithKline, LLC. | 1 | $18 |
| PFIZER INC. | 1 | $16 |
Products named: Wegovy, MOUNJARO, Kerendia, AIRSUPRA, Rybelsus, Tirosint, Cologuard Collection Kit, Ozempic.
Industry payments across NY — which companies pay providers there.
